The DOI matches its Crossref record; 255 of the 255 references it cites were found in a registry or an index.
Protein kinase CK2: a potential therapeutic target for diverse human diseases
Open accessAbstract
CK2 is a constitutively active Ser/Thr protein kinase, which phosphorylates hundreds of substrates, controls several signaling pathways, and is implicated in a plethora of human diseases. Its best documented role is in cancer, where it regulates practically all malignant hallmarks. Other well-known functions of CK2 are in human infections; in particular, several viruses exploit host cell CK2 for their life cycle. Very recently, also SARS-CoV-2, the virus responsible for the COVID-19 pandemic, has been found to enhance CK2 activity and to induce the phosphorylation of several CK2 substrates (either viral and host proteins). CK2 is also considered an emerging target for neurological diseases, inflammation and autoimmune disorders, diverse ophthalmic pathologies, diabetes, and obesity. In addition, CK2 activity has been associated with cardiovascular diseases, as cardiac ischemia–reperfusion injury, atherosclerosis, and cardiac hypertrophy. The hypothesis of considering CK2 inhibition for cystic fibrosis therapies has been also entertained for many years. Moreover, psychiatric disorders and syndromes due to CK2 mutations have been recently identified. On these bases, CK2 is emerging as an increasingly attractive target in various fields of human medicine, with the advantage that several very specific and effective inhibitors are already available. Here, we review the literature on CK2 implication in different human pathologies and evaluate its potential as a pharmacological target in the light of the most recent findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–255 of 255
Shimada, K., Anai, S., Marco, D. A., Fujimoto, K., & Konishi, N. (2011) · BMC Urology · doi:10.1186/1471-2490-11-8 · Cited by 28
Trojan, P., Rausch, S., Gießl, A., Klemm, C., Krause, E., Pulvermüller, A., & Wolfrum, U. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.006 · Cited by 28
Dixit, D., Ahmad, F., Ghildiyal, R., Joshi, S. D., & Sen, E. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.03.017 · Cited by 28
Rabjerg, M., Guerra, B., Oliván‐Viguera, A., Mikkelsen, M. L. N., Köhler, R., Issinger, O., & Marcussen, N. (2016) · Oncotarget · doi:10.18632/oncotarget.13693 · Cited by 28
Im, D.-K., Cheong, H., Lee, J.-S., Oh, M., & Yang, K. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-41852-4 · Cited by 28
Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide
Nitta, R. T., Bolin, S., Luo, E. J., Solow-Cordero, D. E., Samghabadi, P., Purzner, T., Aujla, P. S., Nwagbo, G., Cho, Y., & Li, G. (2019) · Oncogene · doi:10.1038/s41388-019-0927-y · Cited by 28
Protein kinase CK2 is important for the function of glioblastoma brain tumor initiating cells
Rowse, A. L., Gibson, S. A., Meares, G. P., Rajbhandari, R., Nozell, S. E., Dees, K. J., Hjelmeland, A. B., McFarland, B. C., & Benveniste, E. N. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2378-z · Cited by 27
Davis, K. A., Morelli, M., & Patton, J. T. (2017) · mBio · doi:10.1128/mbio.01213-17 · Cited by 27
Protein kinase CK2 is necessary for the adipogenic differentiation of human mesenchymal stem cells
Schwind, L., Wilhelm, N., Kartarius, S., Montenarh, M., Gorjup, E., & Götz, C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.05.023 · Cited by 26
Protein kinase CK2 accumulation in “oncophilic” cells: causes and effects
Ruzzene, M., Tosoni, K., Zanin, S., Cesaro, L., & Pinna, L. A. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0959-2 · Cited by 26
Self-citationDas, N. K., Datta, N., Chatterjee, U., & Ghosh, M. K. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.03.007 · Cited by 26
Zhang, X., Yang, X. F., Yang, C., Li, P., Yuan, W., Deng, X., Cheng, Y., Li, P., Yang, H., Tao, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13571 · Cited by 26
Doliba, N. M., Liu, Q., Li, C., Chen, P., Liu, C., Naji, A., & Matschinsky, F. M. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.07.017 · Cited by 26
Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancer
Jung, M., Park, K. H., Kim, H. M., Kim, T. S., Zhang, X., Park, S.-M., Beom, S., Kim, H. S., Cheong, J., Chung, H. C., et al. (2019) · Gastric Cancer · doi:10.1007/s10120-019-00971-7 · Cited by 26
Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonization
Gottardo, M. F., Capobianco, C. S., Sidabra, J. E., Garona, J., Perera, Y., Perea, S. E., Alonso, D. F., & Fariña, H. G. (2020) · Scientific Reports · doi:10.1038/s41598-020-71854-6 · Cited by 26
Pérez, P. E., Indo, S., Niechi, I., Huerta, H., Cabello, P., Lilian Jara, S., Aguayo, F., Varas‐Godoy, M., Burzio, V. A., & Tapia, J. C. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12609 · Cited by 25
Xu, S., Lian, Q., Wu, J., et al. (2020) · BMC Medical Genetics · doi:10.1186/s12881-020-01096-w · Cited by 25
The Protein Kinase 2 Inhibitor CX-4945 Regulates Osteoclast and Osteoblast Differentiation In Vitro
Son, Y. H., Moon, S. H., & Kim, J. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0184-9 · Cited by 24
CK2 and GSK3 phosphorylation on S29 controls wild-type ATXN3 nuclear uptake
Pastori, V., Sangalli, E., Coccetti, P., Pozzi, C., Nonnis, S., Tedeschi, G., & Fusi, P. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.03.007 · Cited by 23
Maeda, R., Raz, I., ZURLO, F., & Sommercorn, J. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115060 · Cited by 23
Yoo, J., Choi, H., Choi, K., Park, S., Ota, I., Yook, J. I., Lee, Y., Kim, K., & Yoon, H. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-11-0947 · Cited by 23
Schaefer, S., Svenstrup, T. H., & Guerra, B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177706 · Cited by 22
“Janus” efficacy of CX-5011: CK2 inhibition and methuosis induction by independent mechanisms
D’Amore, C., Moro, E., Borgo, C., Itami, K., Hirota, T., Pinna, L. A., & Salvi, M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118807 · Cited by 22
Self-citationCasein kinase 2 interacts with and phosphorylates ataxin-3
Tao, R.-S., Fei, E., Ying, Z., Wang, H., & Wang, G. (2008) · Neuroscience Bulletin · doi:10.1007/s12264-008-0605-5 · Cited by 21
The Acidophilic Kinases PLK2 and PLK3: Structure, Substrate Targeting and Inhibition
Cozza, G., & Salvi, M. (2018) · Current Protein and Peptide Science · doi:10.2174/1389203719666180124095405 · Cited by 21
Self-citationTrembley, J. H., Kren, B. T., Abedin, M. J., Shaughnessy, D. P., Li, Y., Dehm, S. M., & Ahmed, K. (2019) · Pharmaceuticals · doi:10.3390/ph12020089 · Cited by 20
Sanna, M., Borgo, C., Compagnin, C., Favaretto, F., Vindigni, V., Trento, M., Bettini, S., Comin, A., Belligoli, A., Rugge, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217933 · Cited by 20
Self-citationLee, Y. S., Lee, D. Y., Yu, D. Y., Kim, S., & Lee, Y. C. (2014) · Helicobacter · doi:10.1111/hel.12144 · Cited by 19
Regulation of TMEM16A by CK2 and Its Role in Cellular Proliferation
Pinto, M. C., Schreiber, R., Lérias, J. R., Ousingsawat, J., Duarte, A., Amaral, M. D., & Kunzelmann, K. (2020) · Cells · doi:10.3390/cells9051138 · Cited by 19
CK2 is a key regulator of SLC4A2-mediated Cl−/HCO3 − exchange in human airway epithelia
Ibrahim, S. H., Turner, M. J., Saint‐Criq, V., Garnett, J. P., Haq, I., Brodlie, M., Ward, C., Borgo, C., Salvi, M., Venerando, A., et al. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1981-3 · Cited by 18
Self-citationHuang, J., Li, J., Chen, Z., Li, J., Chen, Q., Gong, W., Liu, P., & Huang, H. (2017) · Oncotarget · doi:10.18632/oncotarget.21640 · Cited by 18
da Silva, I. C. D. A., Carneiro, V. C., Maciel, R. D. M., da Costa, R. M., Furtado, D. R., de Oliveira, F. M. B., Silva-Neto, M. A. C., Rumjanek, F. D., & Fantappíé, M. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023572 · Cited by 17
Ribeiro, S. T., Tesio, M., Ribot, J. C., Macintyre, E. A., Barata, J. T., & Silva‐Santos, B. (2016) · Leukemia · doi:10.1038/leu.2016.363 · Cited by 17
Yang, K. M., & Kim, K. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27078 · Cited by 17
Vilardell, J., Alcaraz, E., Sarró, E., Trilla, E., Cuadros, T., de Torres, I. M., Plana, M., y Cajal, S. R., Pinna, L. A., Ruzzene, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23422 · Cited by 16
Self-citationColavito, D., Giudice, E. D., Ceccato, C., et al. (2018) · Journal of Human Genetics · doi:10.1038/s10038-018-0434-y · Cited by 16
P27 Protects Cardiomyocytes from Sepsis via Activation of Autophagy and Inhibition of Apoptosis
Zhao, X., Qi, H., Zhou, J., Xu, S., & Gao, Y. (2018) · Medical Science Monitor · doi:10.12659/msm.912750 · Cited by 16
Basta, H. A., Bacot-Davis, V. R., Ciomperlik, J. J., & Palmenberg, A. C. (2013) · Journal of Virology · doi:10.1128/jvi.03150-13 · Cited by 15
Servas, C., Kiehlmeier, S., Hach, J., Gross, R., Götz, C., & Montenarh, M. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.05.005 · Cited by 15
Understanding protein kinase CK2 mis-regulation upon F508del CFTR expression
Venerando, A., Pagano, M. A., Tosoni, K., Meggio, F., Cassidy, D. M., Stobbart, M., Pinna, L. A., & Mehta, A. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0650-x · Cited by 14
The lysine-specific demethylase 1 is a novel substrate of protein kinase CK2
Costa, R., Arrigoni, G., Cozza, G., Lolli, G., Battistutta, R., Belmonte, J. C. I., Pinna, L. A., & Sarno, S. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.01.014 · Cited by 14
Self-citationKulbe, H., Iorio, F., Chakravarty, P., Milagre, C. S., Moore, R., Thompson, R. G., Everitt, G. L. A., Canosa, M., Montoya, A., Drygin, D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7255 · Cited by 14
Wadey, K. S., Brown, B. A., Sala‐Newby, G. B., Jayaraman, P.-S., Gaston, K., & George, S. J. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2017.09.004 · Cited by 14
Lan, Y., Wang, Y., Chen, H., Lo, S., Chen, S., & Tsai, F. (2019) · International Journal of Medical Sciences · doi:10.7150/ijms.37110 · Cited by 14
Protein kinase CK2 modulates HSJ1 function through phosphorylation of the UIM2 domain
Ottaviani, D., Marin, O., Arrigoni, G., Franchin, C., Vilardell, J., Sandre, M., Li, W., Parfitt, D. A., Pinna, L. A., Cheetham, M. E., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw420 · Cited by 13
Self-citationEmerging JWA-targeted Pt(IV) prodrugs conjugated with CX-4945 to overcome chemo-immune-resistance
Chen, F., Pei, S., Wang, X., Zhu, Q., & Gou, S. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.10.184 · Cited by 13
Contribution of the CK2 Catalytic Isoforms α and α’ to the Glycolytic Phenotype of Tumor Cells
Zonta, F., Borgo, C., Meza, C. P. Q., Masgras, I., Rasola, A., Salvi, M., Pinna, L. A., & Ruzzene, M. (2021) · Cells · doi:10.3390/cells10010181 · Cited by 13
Self-citationGrande, J., Pérez‐Riba, M., Plana, M., & Itarte, E. (1989) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(89)90394-9 · Cited by 12
Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias
Morotti, A., Carrà, G., Panuzzo, C., Crivellaro, S., Taulli, R., Guerrasio, A., & Saglio, G. N. (2015) · Advances in Hematology · doi:10.1155/2015/612567 · Cited by 12
Bitirim, C. V., Tuncay, E., & Turan, B. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3207-6 · Cited by 11
Deciphering the role of protein kinase CK2 in the maturation/stability of F508del-CFTR
D’Amore, C., Borgo, C., Bosello-Travain, V., Vilardell, J., Salizzato, V., Pinna, L. A., Venerando, A., & Salvi, M. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165611 · Cited by 10
Self-citationNew responsibilities for aged kinases in B‐lymphomas
Piazza, F., Manni, S., Arjomand, A., Visentin, A., Trentin, L., & Semenzato, G. (2019) · Hematological Oncology · doi:10.1002/hon.2694 · Cited by 10
Metallo, A., & Villa-Moruzzi, E. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90427-k · Cited by 9
Götz, C., Kartarius, S., Schetting, S., & Montenarh, M. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-2950-2 · Cited by 8
Iori, E., Ruzzene, M., Zanin, S., Sbrignadello, S., Pinna, L. A., & Tessari, P. (2015) · Growth Factors · doi:10.3109/08977194.2015.1073725 · Cited by 4
Self-citation
Cited by
Potential Autoimmunity Resulting from Molecular Mimicry between SARS-CoV-2 Spike and Human Proteins
Nunez-Castilla, J., Stebliankin, V., Baral, P., Balbin, C. A., Sobhan, M., Cickovski, T., Mondal, A. M., Narasimhan, G., Chapagain, P., Mathee, K., et al. (2022) · Viruses · doi:10.3390/v14071415 · Cited by 100
MOTS-c modulates skeletal muscle function by directly binding and activating CK2
Kumagai, H., Kim, S.-J., Miller, B., Zempo, H., Tanisawa, K., Natsume, T., Lee, S. H., Wan, J., Leelaprachakul, N., Kumagai, M. E., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111212 · Cited by 15
Intrinsically Disordered Regions Define Unique Protein Interaction Networks in CHD Family Remodelers
Tabar, M. S., Parsania, C., Giardina, C., Feng, Y., Wong, A. C. H., Metierre, C., Nagarajah, R., Dhungel, B. P., Rasko, J. E. J., & Bailey, C. G. (2025) · The FASEB Journal · doi:10.1096/fj.202402808rr · Cited by 7
Metadata
- Authors
- Borgo, C., D’Amore, C., Sarno, S., Salvi, M., & Ruzzene, M.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2021-05-17
- Volume
- 6
- Issue
- 1
- Pages
- 183-183
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W3162383196
- Cited by
- 362
- References
- 255
- FWCI
- 16.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.